SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRtw Biotech Regulatory News (RTW)

Share Price Information for Rtw Biotech (RTW)

Share Price is delayed by 15 minutes
Get Live Data
2.21    0.00 (0.00%)
Bid:
2.19
Ask:
2.21
Spread: 0.02 (0.913%)
Market Cap: $714.60m
RTW Live PriceLast checked at - London Stock Exchange

Intraday Rtw Biotech Share Chart

Director/PDMR Shareholding

20 Apr 2020 07:00

RNS Number : 1082K
RTW Venture Fund Limited
20 April 2020
 

RTW VENTURE FUND LIMITED

(the "Company")

 

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES ("PDMR") AND PERSONS CLOSELY ASSOCIATED ("PCA") WITH THEM

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

Forest Nominees Limited re William Scott

2

 

Reason for the notification

 

a)

 

Position/status

 

 

William Scott

Director of RTW Venture Fund Limited

 

b)

 

Initial notification /Amendment

 

 

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

RTW Venture Fund Limited

b)

 

LEI

 

 

549300Q7EXQQH6KF7Z84

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary Shares of no par value

 

 

GG00BKTRRM22

 

 

b)

 

Nature of the transaction

 

 

Acquisition of shares purchased as part of the IPO

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

 

$1.0397

 

50,000

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

- Price

 

- Principal amount

 

 

 

 

50,000

 

$1.0397

 

$51,985.00

e)

 

Date of the transaction

 

 

30 October 2019

f)

 

Place of the transaction

 

 

London Stock Exchange, Specialist Fund Segment

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHBIGDSXSBDGGR
Date   Source Headline
12th Jun 20267:00 amRNSMonthly Valuation Update and Factsheet
11th Jun 20264:45 pmRNSResult of AGM
10th Jun 20267:00 amRNSTransaction in Own Shares
8th Jun 20267:00 amRNSTransaction in Own Shares
3rd Jun 20267:00 amRNSTransaction in Own Shares
1st Jun 20267:00 amRNSTotal Voting Rights
20th May 20267:00 amRNSNotice of AGM
14th May 20267:00 amRNSMonthly Valuation Update and Factsheet
12th May 20267:00 amRNSTransaction in Own Shares
8th May 20267:00 amRNSAdditional investment in Windward Bio
6th May 20267:00 amRNSHolding(s) in Company
1st May 20267:00 amRNSTotal Voting Rights
30th Apr 20267:00 amRNSTransaction in Own Shares
29th Apr 20267:00 amRNSTransaction in Own Shares
28th Apr 20267:00 amRNSTransaction in Own Shares
27th Apr 20267:00 amRNSTransaction in Own Shares
24th Apr 20263:00 pmRNSAnnual Financial Report
24th Apr 20267:00 amRNSTransaction in Own Shares
21st Apr 20267:00 amRNSTransaction in Own Shares
20th Apr 20267:00 amRNSKailera completes $625 million IPO
17th Apr 20267:00 amRNSTransaction in Own Shares
16th Apr 20267:00 amRNSReplacement RNS: Monthly Valuation Update
15th Apr 20267:01 amRNSObsidian Therapeutics reverse merger with Galera
15th Apr 20267:00 amRNSMonthly Valuation Update and Factsheet
8th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20267:00 amRNSTransaction in Own Shares
2nd Apr 20267:00 amRNSTransaction in Own Shares
1st Apr 20267:01 amRNSTotal Voting Rights
1st Apr 20267:00 amRNSApellis and Centessa to be acquired
31st Mar 20267:01 amRNSTransaction in Own Shares
31st Mar 20267:00 amRNSAmani closes $25 million Series A financing
30th Mar 20267:01 amRNSTransaction in Own Shares
30th Mar 20267:00 amRNSAnnual Financial Report
27th Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 20267:00 amRNSTransaction in Own Shares
19th Mar 20267:00 amRNSTransaction in Own Shares
18th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:01 amRNSTransaction in Own Shares
16th Mar 20267:01 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSNotice of 2025 Annual Results & Webinar
16th Mar 20267:00 amRNSNotice of 2025 Annual Results & Webinar
13th Mar 20267:01 amRNSTransaction in Own Shares
13th Mar 20267:01 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSMonthly Valuation Update and Factsheet
13th Mar 20267:00 amRNSMonthly Valuation Update and Factsheet
12th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.